ClinicalTrials.gov
ClinicalTrials.gov Menu

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01543906
Recruitment Status : Completed
First Posted : March 5, 2012
Last Update Posted : December 15, 2014
Sponsor:
Information provided by (Responsible Party):
QLT Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2014
  Actual Study Completion Date : August 2014